InvestmentSQURPHARMA
SQURPHARMA Approves Factory BMRE Investment
Announcement summary
- What happened
- SQURPHARMA approved a factory BMRE investment.
- Purpose
- BMRE of the company’s factory
- Facility / project
- Factory BMRE
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
The Board of Directors has recommended 60% cash dividend for the year ended on June 30, 2021. The Board has also approved Tk. 300.00 crore for BMRE, Capital Machineries and Lands for future expansion. Date of AGM: 15.12.2021, Time: 10:00 AM, Venue: Digital Platform. Record Date: 22.11.2021. (cont.1)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 6174d02d03147376ea7e4a46
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.